GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: BV100 (for infusion) | LM 427 | Mycobutin® | Rifabutine
rifabutin is an approved drug (FDA (1992), UK (2003))
Compound class:
Synthetic organic
Comment: Rifabutin is a derivative of rifamycin S and belongs to the ansamycin group of antibacterial compounds [1]. It is on the World Health Organization's Model List of Essential Medicines (link provided in the Classification table, under the Summary tab below) for use as an oral antituberculosis medication.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. UK MHRA (2003) | US FDA (1992) |
| WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 5668 | rifabutin |
Synonyms ![]() |
| BV100 (for infusion) | LM 427 | Mycobutin® | Rifabutine |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
Rifabutin |
| Other databases | |
| CAS Registry No. | 72559-06-9 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL444633 |
| DrugBank Ligand | DB00615 |
| DrugCentral Ligand | 2376 |
| GtoPdb PubChem SID | 464244156 |
| PubChem CID | 135398743 |
| Search Google for chemical match using the InChIKey | ZWBTYMGEBZUQTK-PVLSIAFMSA-N |
| Search Google for chemicals with the same backbone | ZWBTYMGEBZUQTK |
| Search PubMed clinical trials | rifabutin |
| Search PubMed titles | rifabutin |
| Search PubMed titles/abstracts | rifabutin |
| UniChem Compound Search for chemical match using the InChIKey | ZWBTYMGEBZUQTK-PVLSIAFMSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | ZWBTYMGEBZUQTK-PVLSIAFMSA-N |
| Wikipedia | Rifabutin |